BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8441383)

  • 1. Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.
    Foord O; Navot N; Rotter V
    Mol Cell Biol; 1993 Mar; 13(3):1378-84. PubMed ID: 8441383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
    Furlong EE; Rein T; Martin F
    Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site.
    Kanda T; Segawa K; Ohuchi N; Mori S; Ito Y
    Mol Cell Biol; 1994 Apr; 14(4):2651-63. PubMed ID: 8139565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
    Pastorcic M; Das HK
    J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Miyashita T; Reed JC
    Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
    Morris GF; Bischoff JR; Mathews MB
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
    Liu X; Miller CW; Koeffler PH; Berk AJ
    Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.
    Ronen D; Rotter V; Reisman D
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4128-32. PubMed ID: 1851994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
    Datta B; Li B; Choubey D; Nallur G; Lengyel P
    J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the human hsp70 promoter by p53.
    Agoff SN; Hou J; Linzer DI; Wu B
    Science; 1993 Jan; 259(5091):84-7. PubMed ID: 8418500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
    Ludes-Meyers JH; Subler MA; Shivakumar CV; Munoz RM; Jiang P; Bigger JE; Brown DR; Deb SP; Deb S
    Mol Cell Biol; 1996 Nov; 16(11):6009-19. PubMed ID: 8887630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
    Saifudeen Z; Du H; Dipp S; El-Dahr SS
    J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.